1627.1 – Point-of-care testing for sexually transmitted infections provided by Aboriginal Medical Services or Aboriginal Community Controlled Heath Services in rural or remote areas

Page last updated: 09 February 2024

Application Detail

Description of Medical Service

Rapid on-demand nucleic acid amplification test for use at point-of-care in clinics servicing remote communities enabling laboratory equivalent, on-the-spot diagnosis for Chlamydia trachomatis, Neisseria gonorrhoea, and/or Trichomonas vaginalis infection within 90 minutes, facilitating antibiotic treatment for patients and initiation of contact tracing.

Description of Medical Condition

Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis are sexually transmitted bacterial infections, often asymptomatic, mostly affecting young people aged 15-29 years. Easily cured with antibiotics, untreated infection can cause pelvic inflammatory disease resulting in chronic abdominal pain, as well as increasing the risk of tubal infertility and ectopic pregnancy.

Reason for Application

New MBS items

Medical Service Type

Investigative

Previous Application Number/s

1627

Associated Documentation

Application Form

Application Form (PDF 1593 KB)
Application Form (Word 443 KB)

Consultation Survey


PASC Consultation
Not applicable

MSAC Consultation
Not applicable

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

See application 1627

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 524 KB)
Public Summary Document (Word 214 KB)

Meetings for this Application

PASC

Expedited - bypassing PASC

ESC

Expedited - bypassing ESC

MSAC

23-24 November 2023